Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

30

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

Tags:

Previous Article

Timescapes of non-human experience

Parkinson's medication shows promise in treating depression

Related Posts

A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity

A role for leucine-rich, glioma inactivated 1 in regula...

97

LassoESM a tailored language model for enhanced lasso peptide property prediction

LassoESM a tailored language model for enhanced lasso p...

59

Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype

Oral microbiome and nitric oxide biomarkers in older pe...

91